Healthcare company Baxter International (NYSE:BAX) met Wall Street's revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter's revenue ...
“For the second quarter of 2025, Baxter delivered performance in line with guidance while our employees across the globe continued advancing the company's life-sustaining Mission and building on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results